We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Connected Devices to Change Healthcare Delivery

By HospiMedica International staff writers
Posted on 11 Nov 2013
Organizations across the healthcare value chain are realizing the potential of embedding machine-to-machine (M2M) technology into mobile health solutions. More...
These are the latest findings of Frost & Sullivan (Frost, Mountain View, CA, USA), an international market research firm.

Governments, health organizations, and insurers looking for ways to streamline healthcare delivery and control costs have begun to develop M2M-enabled solutions for various applications, including remote patient monitoring, medical asset tracking, and healthcare workflow organization. The Frost report details the success of Orange Business Services (Paris, France) and Telefonica (Madrid, Spain), two mobile network operators (MNOs) in building a stronger presence in the healthcare industry.

The report finds that after North America, Europe offers considerable growth potential for M2M in healthcare, as most European telecom operators have now dedicated M2M business units that focus on research and development, service development, and delivery. But M2M providers for the healthcare sector will need to combat a significant degree of device fragmentation, understand strict local regulations, and be capable of dealing with a broad range of industry stakeholders. To successfully integrate M2M solutions into the healthcare system, providers will also have to offer value added service along with basic connectivity.

Such value-added services include legal compliance, analytics, consulting, and integration, which will require the creation of a sustainable ecosystem of stakeholders and collaboration partners from both the healthcare and technology industries. As a result, MNOs must build health-related resources and expertise to be able to offer highly specialized M2M solutions. Designing a powerful M2M infrastructure supporting various healthcare needs and securing medical data hosting capabilities will also prove essential.

“MNOs are well-placed to participate in shaping future healthcare delivery, as they own the essential communications infrastructure needed for mobile communications to become a core tool in the industry,” said Frost information and communication technologies research analyst Malgorzata Filar. “They have also built trust with their customers and can supply user-centric services.”

Frost estimates that M2M revenues of telecom service providers in Europe will grow to EUR 2.6 billion by 2016, up from EUR 600 million in 2010.

Related Links:

Frost & Sullivan
Orange Business Services
Telefonica



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.